1.402160 重庆,重庆医科大学附属永川医院:骨科(脊柱)
2.402160 重庆,重庆医科大学附属永川医院:中心实验室
Received:16 November 2020,
Revised:2020-12-25,
Published:15 April 2021
移动端阅览
Meichao DENG, Hongjun ZHANG, Zhongzu ZHANG, et al. Efficacy of mixed bone cement (PMMA/CPC) versus PMMA in treatment of osteoporotic vertebral compression fractures[J]. Journal of Third Military Medical University, 2021, 43(7): 655-662.
Meichao DENG, Hongjun ZHANG, Zhongzu ZHANG, et al. Efficacy of mixed bone cement (PMMA/CPC) versus PMMA in treatment of osteoporotic vertebral compression fractures[J]. Journal of Third Military Medical University, 2021, 43(7): 655-662. DOI: 10.16016/j.1000-5404.202011143.
目的
2
比较经皮椎体成形术(percutaneous vertebroplasty,PVP)中采用混合骨水泥[聚甲基丙烯酸甲酯(polymethylmethacrylate,PMMA)∶磷酸钙骨水泥(calcium phosphate cement,CPC)=1∶1]与单独采用PMMA治疗骨质疏松性椎体压缩骨折(osteoporotic vertebral compression fracture,OVCF)的临床疗效。
方法
2
采用病例对照研究的方法,收集2018年1-8月在我科行PVP手术满2年的OVCF患者的临床资料,共69例,其中36例填充物为混合骨水泥(混合组),33例填充物为PMMA(PMMA组)。比较两组患者的一般情况、临床疗效指标[疼痛视觉模拟量表(visual analog scale
VAS)评分和Oswestry功能障碍指数(Oswestry disability index
ODI)评分]、并发症(临近椎体骨折和骨水泥渗漏)以及放射学指标(椎体矢状指数和cobb角)。
结果
2
两组患者手术均顺利完成,未出现严重并发症,后期随访未出现严重的后凸畸形。混合组和PMMA组患者在年龄、性别、骨密度、骨折椎体分布情况、手术时间、术中出血量、骨水泥注入量方面差异无统计学意义;两组患者术后疼痛VAS评分、ODI评分较术前均明显下降(
P
<
0.05),各时间点组间差异无统计学意义;在临近椎体骨折的发生方面,混合组低于PMMA组(11.1%
vs
30.3%),差异有统计学意义(
P
=0.048);在骨水泥渗漏方面,混合组的渗漏多于PMMA组(27.8%
vs
15.1%),但差异无统计学意义(
P
=0.204);同时
随访CT发现混合填充物在椎体中有部分被骨组织吸收替代。
结论
2
PVP采用混合骨水泥治疗OVCF安全有效,且混合骨水泥在减少邻近椎体骨折的发生方面更有优势。
Objective
2
To compare the efficacy of percutaneous vertebroplasty (PVP) using polymethyl methacrylate (PMMA)/calcium phosphate cement (CPC) (1∶1) and PMMA alone for osteoporotic vertebral compression fractures (OVCFs).
Methods
2
A retrospective case-control study was conducted in 69 OVCFs patients with whole clinical data of 2 year's follow-up undergoing PVP in our department between January and August 2018. Thirty-six patients received PMMA/CPC (mixed group) and 33 patients PMMA alone (PMMA group). The general and perioperative data
clinical efficacy [visual analog scale (VAS) and Oswestry disability index (ODI)]
postoperative complications (cement leakage and incidence of adjacent vertebral fracture within 2 years after operation) and postoperative radiological data (anterior vertebral height and Cobb angle) were compared between the 2 groups.
Results
2
The operations were s
uccessful among all the patients
and no severe complications or kyphosis occurred. There were no significant differences in age
gender
bone density
distribution of fracture vertebral body
operation time
volume of bleeding
and injection volume of bone cement between the mixed and PMMA groups. The pain VAS score and ODI score were decreased significantly in both groups after operation (
P
<
0.05)
and no differences were seen in the scores at each time point between them. The PMMA group had much higher in the incidence of adjacent vertebral failure than the mixed group (30.3%
vs
11.1%
P
=0.048) during the follow-up. The mixed group had significantly higher incidences of cement leakage (27.8%
vs
15.1%)
though no statistical difference (
P
=0.204). The follow-up CT scanning also found that mixed fillers were partially absorbed by bone tissue in the vertebral body.
Conclusion
2
Mixed bone cement PMMA/CPC is safe and effective in PVP treatment for OVCFs
and shows better performance in reducing the occurrence of adjacent vertebral fractures than PMMA alone.
HE Z, ZHAI Q, HU M, et al. Bone cements for percutaneous vertebroplasty and balloon kyphoplasty: Current status and future developments[J]. J Orthop Translat, 2015, 3(1): 1-11. DOI:10.1016/j.jot.2014.11.002.
KIM M J, LINDSEY D P, HANNIBAL M, et al. Vertebroplasty versus kyphoplasty: biomechanical behavior under repetitive loading conditions[J]. Spine (Phila Pa 1976), 2006, 31(18): 2079-2084. DOI:10.109 7/01.brs.0000231714.15876.76.
LU Q F, LIU C, WANG D S, et al. Biomechanical evaluation of calcium phosphate-based nanocomposite versus polymethylmethacrylate cement for percutaneous kyphoplasty[J]. Spine J, 2019, 19(11): 1871-1884. DOI:10.1016/j.spinee.201 9.06.007.
ZHU R S, KAN S L, NING G Z, et al. Which is the best treatment of osteoporotic vertebral compression fractures: balloon kyphoplasty, percutaneous vertebroplasty, or non-surgical treatment? A Bayesian network meta-analysis[J]. Osteoporos Int, 2019, 30(2): 287-298. DOI:10.1007/s00198-018-480 4-2.
GARFIN S R, YUAN H A, REILEY M A. New technologies in spine: kyphoplasty and vertebroplasty for the treatment of painful osteoporotic compression fractures[J]. Spine (Phila Pa 1976), 2001, 26(14): 1511-1515. DOI:10.1097/00007632-200107150-00002.
LIEBERMAN I H, TOGAWA D, KAYANJA M M. Vertebroplasty and kyphoplasty: filler materials[J]. Spine J, 2005, 5(6 Suppl): 305S-316S. DOI:10.1016/j.spinee.2005. 02.020.
BELKOFF SM, MOLLOY S. Temperature measurement during polymerization of polymethylmethacrylate cement used for vertebroplasty[J]. Spine (Phila Pa 1976), 2003, 28(14): 1555-1559.
KLAZEN C A, LOHLE P N, DE VRIES J, et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos Ⅱ): an open-label randomised trial[J]. Lancet, 2010, 376(9746): 1085-1092. DOI:10.1016/S0 140-6736(10)60954-3.
邱贵兴, 裴福兴, 胡侦明, 等. 中国骨质疏松性骨折诊疗指南——骨质疏松性骨折诊断及治疗原则[J]. 黑龙江科学, 2018, 9(2): 85-88, 95.
QIU G X, PEI F X, HU Z M, et al. Guide to diagnosis and treatment of osteoporotic fracture in China——osteoporotic fracture diagnosis and treatment principles[J]. Heilongjiang Sci, 2018, 9(2): 85-88, 95.
LAU E, ONG K, KURTZ S, et al. Mortality following the diagnosis of a vertebral compression fracture in the Medicare population[J]. J Bone Joint Surg Am, 2008, 90(7): 1479-1486. DOI:10.2106/jbjs.g.00675.
BOGER A, HEINI P, WINDOLF M, et al. Adjacent vertebral failure after vertebroplasty: a biomechanical study of low-modulus PMMA cement[J]. Eur Spine J, 2007, 16(12): 2118-2125. DOI:10.1007/s 00586-007-0473-0.
LIN D S, HAO J M, LI L, et al. Effect of bone cement volume fraction on adjacent vertebral fractures after unilateral percutaneous kyphoplasty[J]. Clin Spine Surg, 2017, 30(3): E270-E275. DOI:10.1097/BSD.0000000000000204.
TAYLOR R S, TAYLOR R J, FRITZELL P. Balloon kyphoplasty and vertebroplasty for vertebralcompression fractures: a comparative systematic review of efficacy and safety[J]. Spine (Phila Pa 1976), 2006, 31(23): 2747-2755. DOI:10.1097/01.brs.0000244639.71656.7d.
LARSSON S, HANNINK G. Injectable bone-graft substitutes: current products, their characteristics and indications, and new developments[J]. Injury, 2011, 42(Suppl 2): S30-S34. DOI:10.1016/j.injury.2011.06.013.
BURGUERA E F, XU H H, WEIR M D. Injectable and rapid-setting calcium phosphate bone cement with dicalcium phosphate dihydrate[J]. J Biomed Mater Res B Appl Biomater, 2006, 77(1): 126-134. DOI: 10.1002/jbm.b.30403.
NAKANO M, HIRANO N, MATSUURA K, et al. Percutaneous transpedicular vertebroplasty with calcium phosphate cement in the treatment of osteoporotic vertebral compression and burst fractures[J]. J Neurosurg, 2002, 97(3 suppl): 287-293. DOI:10.317 1/spi.2002.97.3.0287.
NAKANO M, HIRANO N, ZUKAWA M, et al. Vertebroplasty using calcium phosphate cement for osteoporotic vertebral fractures: study of outcomes at a minimum follow-up of two years[J]. Asian Spine J, 2012, 6(1): 34-42. DOI:10.4184/asj.2012.6.1.34.
RYU K S, SHIM J H, HEO H Y, et al. Therapeutic efficacy of injectable calcium phosphate cement in osteoporotic vertebral compression fractures: prospective nonrandomized controlled study at 6-month follow-up[J]. World Neurosurg, 2010, 73(4): 408-411. DOI:10.1016/j.wneu.2010.01.006.
YOSHⅡ T, UEKI H, KATO T, et al. Severe kyphotic deformity resulting from collapses of cemented and adjacent vertebrae following percutaneous vertebroplasty using calcium phosphate cement. A case report[J]. Skeletal Radiol, 2014, 43(10): 1477-1480. DOI:10.1007/s00256-014-1912-8.
AGHYARIAN S, RODRIGUEZ L C, CHARI J, et al. Characterization of a new composite PMMA-HA/Brushite bone cement for spinal augmentation[J]. J Biomater Appl, 2014, 29(5): 688-698. DOI:10.1177/0885328214544770.
AGHYARIAN S, HU X B, LIEBERMAN I H, et al. Two novel high performing composite PMMA-CaP cements for vertebroplasty: an ex vivo animal study[J]. J Mech Behav Biomed Mater, 2015, 50: 290-298. DOI:10.1016/j.jmbbm.2015.06.022.
包利, 唐海, 王炳强, 等. CPC/PMMA双向骨水泥性能及生物相容性的初步研究[J]. 中国骨质疏松杂志, 2012, 18(5): 420-424.
BAO L, TANG H, WANG B Q, et al. Preliminary study on properties and biocompatibility of CPC/PMMA dual-phase bone cement[J]. Chin J Osteoporos, 2012, 18(5): 420-424.
YANG J, ZHANG K R, ZHANG S, et al. Preparation of calcium phosphate cement and polymethyl methacrylate for biological composite bone cements[J]. Med Sci Monit, 2015, 21: 1162-1172. DOI: 10.12659/MSM.893845.
KOMANG-AGUNG I S, HYDRAVIANTO L, SINDRAWATI O, et al. Effect of polymethylmethacrylate-hydroxyapatite composites on callus formation and compressive strength in goat vertebral body[J]. Malays Orthop J, 2018, 12(3): 6-13. DOI:10.5704/moj.1811.002.
ADACHI T, OSAKO Y, TANAKA M, et al. Framework for optimal design of porous scaffold microstructure by computational simulation of bone regeneration[J]. Biomaterials, 2006, 27(21): 3964-3972. DOI:10.101 6/j.biomaterials.2006.02.039.
ZHANG X, KANG T, LIANG P Q, et al. Biological activity of an injectable biphasic calcium phosphate/PMMA bone cement for induced osteogensis in rabbit model[J]. Macromol Biosci, 2018, 18(3): 1700331. DOI: 10.1002/mabi.201700331.
WANG X, KOU J M, YUE Y, et al. Clinical outcome comparison of polymethylmethacrylate bone cement with and without mineralized collagen modification for osteoporotic vertebral compression fractures[J]. Medicine (Madr), 2018, 97(37): e12204. DOI:10.1097/md.0000000000012204.
姜文康, 耿伟, 许莹莹, 等. 矿化胶原改性骨水泥在骨质疏松性椎体压缩骨折中的应用[J]. 中国组织工程研究, 2020, 24(15): 2381-2386. DOI:10.3969/j.issn.20 95-4344.2603.
JIANG W K, GENG W, XU Y Y, et al. Application of mineralized collagen modified bone cement in the treatment of osteoporotic vertebral compression fractures[J]. Chin J Tissue Eng Res, 2020, 24(15): 2381-2386. DOI:10.3969/j.issn.2095-4344.2603.
ZHANG J T, LIU W Z, SCHNITZLER V, et al. Calcium phosphate cements for bone substitution: chemistry, handling and mechanical properties[J]. Acta Biomater, 2014, 10(3): 1035-1049. DOI:10.1016/j.actbio.2013.11. 001.
GALOVICH L A, PEREZ-HIGUERAS A, ALTONAGA J R, et al. Biomechanical, histological and histomorphometric analyses of calcium phosphate cement compared to PMMA for vertebral augmentation in a validated animal model[J]. Eur Spine J, 2011, 20(Suppl 3): 376-382. DOI:10.1007/s00586-011-1905-4.
DE LACERDA SCHICKERT S, PINTO J C, JANSEN J, et al. Tough and injectable fiber reinforced calcium phosphate cement as an alternative to polymethylmethacrylate cement for vertebral augmentation: a biomechanical study[J]. Biomater Sci, 2020, 8(15): 4239-4250. DOI:10.1039/d0bm00413h.
LIN B J, LI C C, MA H I. Intradural cement leakage after percutaneous vertebroplasty[J]. Turk Neurosurg, 2015, 25(6): 940-942. DOI:10.5137/1019- 5149.JTN.11079-14.1.
赵敏超, 武汉. 骨水泥材料在椎体成形术中的研究进展[J]. 医学综述, 2018, 24(17): 3409-3413, 3418. DOI:10.3969/j.issn.1006-2084.2018.17.016.
ZHAO M C, WU H. Research progress of bone cement in vertebroplasty[J]. Med Recapitul, 2018, 24(17): 3409-3413, 3418. DOI:10.3969/j.issn.1006-2084.201 8.17.016.
ZHAN Y, JIANG J, LIAO H, et al. Risk factors for cement leakage after vertebroplasty or kyphoplasty: a meta-analysis of published evidence[J]. World Neurosurg, 2017, 101: 633-642. DOI: 10.1016/j.wneu. 2017.01.124.
MAESTRETTI G, CREMER C, OTTEN P, et al. Prospective study of standalone balloon kyphoplasty with calcium phosphate cement augmentation in traumatic fractures[J]. Eur Spine J, 2007, 16(5): 601-610. DOI: 10.1007/s00586-006-0258-x.
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
